Norman Noble Extends Reach in Implant Manufacturing MarketNorman Noble Extends Reach in Implant Manufacturing Market
Wireless data collected directly from patients during normal physical activities could enable the development of better knee implants
September 15, 2008
Originally Published MPMN September 2008
MD&M MIDWEST 2008: EXHIBITOR NEWS
Norman Noble Extends Reach in Implant Manufacturing Market
The addition of multiple milling machines expands Norman Noble's ability to machine orthopedic products, such as fixation plates.
Norman Noble (Highland Heights, OH), a contract manufacturer serving the medical device industry, has announced that it has expanded its orthopedic implant manufacturing capabilities. The company maintains that the recent addition of eight Willemin-Macodel five-axis contour milling machines establishes it as one of the largest providers of single-operation machining to the orthopedic implant market.
Acting in response to a growing demand in the market, Norman Noble acquired the machining equipment in an effort to secure a position as a leader in the surging implant manufacturing sector. “The U.S. spinal implant market alone is valued at $3 billion with sizable recent and forecasted growth,” says Dan Stefano, vice president of manufacturing, Norman Noble. “This additional technology and capacity fits our experience in manufacturing for this market, which requires tight tolerances, complex geometries, and unique finishing requirements.”
Suited for machining such parts as spinal and extremity implants, the Willemin-Macodel systems can be automated so that milling and turning operations are combined in one cycle. This capability can yield a higher output coupled with greater precision and quality than other implant manufacturing methods, according to the company. Additional investments toward serving the orthopedics market include increased capacity in Swiss turning and milling. Equipment investments have also been made in the quality inspection department.
Strengthening its offerings to implant OEMs is one component of Norman Noble’s ongoing strategy to maintain double-digit growth. During the past several years, the company has doubled the size of its facilities and has invested in its Swiss turning, laser machining, and finishing technologies. The company is also currently undergoing a $1.7 million expansion of its mass finishing operation to support R&D and automated production.
Norman Noble Inc.
Copyright ©2008 Medical Product Manufacturing News
You May Also Like